Skip to main content

Table 2 Characteristics of patients included in the immunoblot study

From: Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease

Variable

Controls (N = 3)

AD patients (N = 4)

Age at death (years)

  

 Median [IQR]

73.0 [69.0-92.0]

73.0 [72.0-73.0]

 Range

69.0-92.0

72.0, 89.0

Sex – n of patients (%)

  

 Female

1 (33.3)

2 (50.0)

 Male

2 (66.6)

2 (50.0)

Post mortem interval

  

 Median [IQR]

36.5 [10.0-63.0]

56.5 [44.0-59.0]

 Range

10.0-63.0

44.0, 59.0

 Missing (n)

1

 

Braak Stage – n of patients (%)

  

 0

2 (66.6)

 

 II

1 (33.3)

 

 VI

 

4 (100.0)

Thal – n of patients (%)

  

 0

3 (100.0)

 

 4

 

1 (25.0)

 5

 

3 (75.0)